Clinical trial Recruiting at 1 site Observational Ages 18 and up

Outcomes for people hospitalized with coronary artery disease

Official title: Clinical Outcomes of Patients With Coronary Artery Disease Cohort Study

Run by Shenyang Northern Hospital · NCT06216847 · Data updated 2026-11-12

This project will see how diagnostic tests and real-world treatment choices relate to outcomes for adults hospitalized with confirmed or suspected coronary heart disease.

More Coronary Heart Disease (CHD) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorShenyang Northern Hospital
Academic / other
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedFebruary 21, 2024
Main results expectedOctober 31, 2026
Study endsOctober 31, 2030
Registry record updatedSeptember 10, 2025
Trial IDNCT06216847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age 18+) hospitalized with confirmed or suspected coronary heart disease who can provide consent and who undergo at least one coronary imaging and one functional test are ideal candidates.

Probably not a fit

People who cannot complete required imaging or functional testing, who have very limited life expectancy, or who cannot participate in follow-up are unlikely to benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multi-center cohort enrolling adults hospitalized with confirmed or suspected coronary heart disease to build a comprehensive clinical and imaging dataset. Participants will undergo at least one coronary imaging test (CTA, IVUS, or OCT) and one functional assessment (FFR, CT-FFR, or QFR), with treatments and outcomes recorded over time. The investigators will combine lesion-level imaging, lab and clinical data to explore inflammation-related risk, lesion-based risk stratification, and real-world antithrombotic strategies. Big-data mining methods will be used to derive risk models and optimize clinical decision pathways.

Why it matters

Potential benefit: If successful, the findings could help doctors personalize diagnosis and treatment plans to reduce heart attacks and other bad outcomes in people with coronary disease.

How similar studies have gone: Large registries and cohort studies have yielded valuable real-world insights for coronary disease, but combining detailed lesion imaging, functional testing, and big-data analytics in a single 'holographic' dataset is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years old
* Hospitalization due to either confirmed or suspected CHD combined with one of the following features: previous PCI or CABG; previous myocardial infarction; previous coronary angiography revealing ≥ 50% stenosis in major coronary vessels; presentation with chest pain and pre-test probability of CHD \> 65%; laboratory tests revealing objective evidence of myocardial ischemia; coronary CT angiography (CTA) showed ≥ 30% stenosis in major coronary vessels
* Subjects undergoing at least one coronary imaging and one functional examination. Imaging examinations include coronary CTA, intravascular ultrasound (IVUS), or optical coherence tomography (OCT). Functional examination include fraction flow reservation (FFR), CT-FFR or quantitative flow ratio (QFR).
* Written informed consent provided.

Exclusion Criteria:

* History of mental illness, drug or alcohol abuse, or being unable to cooperate with follow-up visits for any reason;
* Life expectancy \<1 year
* Pregnant or plan to be pregnant within 1 year
* Subjects participating in any other clinical trial
* Other conditions deemed unsuitable for inclusion by the investigator

Where it's running

  • General Hospital of Northern Theater Command
    Shenyang, Liaoning, China
    Recruiting

Study contacts

  • Principal investigator: Yaling Han, MD — The General Hospital of Northern Theater Command
  • Study coordinator: Yi Li, MD
  • Email: doctorliyi@126.com
  • Phone: +86-24-28897309

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.